Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Recursion Pharmaceuticals Inc’s current trading price is -60.03% away from its 52-week high, while its distance from the 52-week low is 30.34%. The stock’s price range over this period has fluctuated between $3.79 and $12.36. The company, operating within the financial sector, had a trading volume of approximately 19.81 million for the day, which was noticeably lower than the average daily share volume of 27.84 million over the last 3 months.
At present, Recursion Pharmaceuticals Inc (RXRX) has a stock price of $4.94. In the previous session, the stock saw a rise, peaking at $10.0 after an opening price of $4.94. The day’s lowest price was $3.0, and it closed at $4.78.
Recursion Pharmaceuticals Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $12.36 on 02/18/25, while the lowest price for the same period was registered at $3.79 on 04/09/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Recursion Pharmaceuticals Inc (RXRX) has experienced a quarterly rise of 19.18% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.14B.
Recursion Pharmaceuticals Inc: What Analysts Are Saying
As of right now, 1 analyst is rating Recursion Pharmaceuticals Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 6 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.17, with a change in price of -0.35. Similarly, Recursion Pharmaceuticals Inc recorded 25,712,113 in trading volume during the last 100 days, posting a change of -6.62%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for RXRX stands at 0.10. Similarly, the long-term debt-to-equity ratio is also 0.07.
RXRX Stock Stochastic Average
Today’s raw stochastic average for Recursion Pharmaceuticals Inc over the last 50 days is 9.05%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 11.20%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 5.43% and 9.52%, respectively.
RXRX Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Year to date metric has recorded a loss of -31.01%.However, over the last six months, we can see a stronger performance of -46.77%. Over the last 30 days, the price of RXRX has leaped by -21.09%. And in the last five days, it has fallen by -14.38%.
